AdvanceMarketAnalytics, a global market research and consulting organization, have released a new study titled "Sleep Disorder Treatment Drugs market - Global outlook to 2024". Industries constant focus on reducing the operational cost and increased attention on core business, and need to improve scalability are expected to shape the Global Sleep Disorder Treatment Drugs market to grow at a CAGR of 5.5%.
The Sleep disorder, such as Insomnia, is boosting the Sleep Disorder Treatment Drugs market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
The Devices, such as Positive Airway Pressure (PAP) Devices, is boosting the Sleep Disorder Treatment Drugs market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
According to AMA research team, the Global Sleep Disorder Treatment Drugs market will experience significant growth during the forecast period due to potential opportunities lying in the market such as . Some of the important driving forces are Increasing Incidence of Depression & Medical Disorder, Rising Geriatric Population and Associated Sleep Disorder and High Usage of Sleep Apnea Devices and Growing Healthcare Facilities. †
Sleep disorder is also known as sominpathy or insomnia is a medical disorder in which the patient experience difficulty in sleep maintenance or sleep initiation. Symptoms for this disorder include mental, physical, social, and emotional functions. Lack of sleep has a negative impact on the health of a person. The prevalence of sleep disorders has been significantly increased which is a primary factor fostering the market growth. Reportedly, in the United States, over 75% of people aged between 20 and 59 years have sleeping difficulties frequently.
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global Sleep Disorder Treatment Drugs market by Type (Prescription-based Drugs, OTC Drugs and Herbal Drugs), by Application (Hospitals, Clinics, Research Centers and Others) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key trends (current and future) of the market